NASDAQ:BLGO BioLargo (BLGO) Stock Price, News & Analysis $0.20 +0.02 (+11.42%) (As of 12/20/2024 04:34 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrends About BioLargo Stock (NASDAQ:BLGO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BioLargo alerts:Sign Up Key Stats Today's Range$0.17▼$0.2050-Day Range$0.18▼$0.2452-Week Range$0.16▼$0.45Volume653,176 shsAverage Volume294,869 shsMarket Capitalization$60.21 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewBioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.Read More… Receive BLGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioLargo and its competitors with MarketBeat's FREE daily newsletter. Email Address BLGO Stock News HeadlinesBioLargo CEO Dennis Calvert appoints to Department of Commerce’s ETTACDecember 12, 2024 | markets.businessinsider.comBioLargo, Inc. CEO Dennis P. Calvert Appointed to U.S. Department of Commerce Environmental Technologies Trade Advisory CommitteeDecember 12, 2024 | finanznachrichten.de70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.December 21, 2024 | WealthPress (Ad)BioLargo Shares Strategic Updates in Investor WebcastNovember 16, 2024 | markets.businessinsider.comBioLargo reports Q3 revenue $4.4M vs. $2.7M last yearNovember 16, 2024 | markets.businessinsider.comBioLargo (BLGO)November 1, 2024 | es.investing.comCleanTech Innovator Delivers Long-Range, Safe Battery TechOctober 28, 2024 | msn.comBioLargo Inc (BLGO) Q2 2024 Earnings Call Highlights: Record Revenues and Strategic Growth ...October 9, 2024 | finance.yahoo.comSee More Headlines BLGO Stock Analysis - Frequently Asked Questions How have BLGO shares performed this year? BioLargo's stock was trading at $0.1680 at the beginning of the year. Since then, BLGO stock has increased by 19.0% and is now trading at $0.20. View the best growth stocks for 2024 here. How do I buy shares of BioLargo? Shares of BLGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of BioLargo own? Based on aggregate information from My MarketBeat watchlists, some other companies that BioLargo investors own include Hydrofarm Holdings Group (HYFM), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Meta Platforms (META), Micron Technology (MU), Petróleo Brasileiro S.A. - Petrobras (PBR) and Clean Energy Fuels (CLNE). Company Calendar Today12/21/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConstruction Industry Chemicals & allied products Sub-IndustryChemicals Current SymbolNASDAQ:BLGO CUSIPN/A CIK880242 Webwww.biolargo.com Phone(888) 400-2863Fax949-625-9819Employees30Year Founded1989Profitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,500,000.00 Net Margins-11.45% Pretax Margin-19.65% Return on Equity-39.90% Return on Assets-22.06% Debt Debt-to-Equity Ratio0.03 Current Ratio2.31 Quick Ratio2.24 Sales & Book Value Annual Sales$12.23 million Price / Sales4.92 Cash FlowN/A Price / Cash FlowN/A Book Value$0.01 per share Price / Book20.00Miscellaneous Outstanding Shares301,065,000Free Float239,869,000Market Cap$60.21 million OptionableNot Optionable Beta0.18 Social Links 10 Best Stocks to Own in 2025Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio. Get This Free Report This page (NASDAQ:BLGO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLargo, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLargo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.